Birth defects following exposure to efavirenz-based antiretroviral therapy during pregnancy: a study at a regional South African hospital.
about
Antiretroviral therapy, pregnancy, and birth defects: a discussion on the updated data.Quantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the USAPregnancy outcomes in women exposed to efavirenz and nevirapine: an appraisal of the IeDEA West Africa and ANRS Databases, Abidjan, Côte d'Ivoire.First trimester exposure to antiretroviral therapy and risk of birth defectsNew option for management of HIV-1 infection in treatment-naive patients: once-daily, fixed-dose combination of rilpivirine-emtricitabine-tenofovir.Efavirenz conceptions and regimen management in a prospective cohort of women on antiretroviral therapy.Fatal toxicity from symptomatic hyperlactataemia: a retrospective cohort study of factors implicated with long-term nucleoside reverse transcriptase inhibitor use in a South African hospital.Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing age.Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding.High pregnancy intentions and missed opportunities for patient-provider communication about fertility in a South African cohort of HIV-positive women on antiretroviral therapy.Encephalocele following a periconceptional exposure to efavirenz: a case report.Efavirenz-based combination antiretroviral therapy after peripartum single-dose nevirapine.
P2860
Q30661395-B71F20EB-0B42-4D0E-8786-711D79A7D086Q34440857-17497680-5D8D-4D8E-850D-EA4CCF0A2EFEQ34609879-611C0886-160B-4A83-8B0A-8A2FC05B7A89Q35572618-C686D4B4-B513-4E55-8EFA-027AB9157FF4Q35939695-2D51ACCE-B533-4FA3-99E9-202CFC597BC7Q36063532-784239AE-6C18-48DB-A439-A19921341D0EQ37123310-9DDF69BC-9745-402C-B894-E0EADFEF7734Q37326983-E5A11D45-7C7C-4881-85B6-70F58CC0BCE3Q38051400-8C39ED38-9AEF-4615-9321-0D08DAB2118CQ39741284-EED90C2B-2F7C-4428-83C0-570D11FB0D09Q42239227-0534F9ED-3E61-4D11-AEAF-9AA2D16C8B0DQ43467646-E6B51C3A-0A1F-466C-BC77-8F9C09804603
P2860
Birth defects following exposure to efavirenz-based antiretroviral therapy during pregnancy: a study at a regional South African hospital.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Birth defects following exposu ...... gional South African hospital.
@en
Birth defects following exposu ...... gional South African hospital.
@nl
type
label
Birth defects following exposu ...... gional South African hospital.
@en
Birth defects following exposu ...... gional South African hospital.
@nl
prefLabel
Birth defects following exposu ...... gional South African hospital.
@en
Birth defects following exposu ...... gional South African hospital.
@nl
P2093
P1433
P1476
Birth defects following exposu ...... gional South African hospital.
@en
P2093
Batembu Mgudlwa
Busiwe Majeke
Ebrahim Bera
Katrin McCausland
Roxaan Nonkwelo
Saji Chacko
P304
P356
10.1097/QAD.0B013E328333AF32
P407
P577
2010-01-01T00:00:00Z